 |
 |
 |
|
Pharmacokinetics/Pharmacodynamics and Virological Activity of VH3810109 (N6LS) in Antiretroviral-Naive Viremic Adults
From the Phase 2a BANNER Study
|
|
|
EACS 2023 Oct 18-21
A. Yin Edwards,1* Waqar Ashraf,1* Thijs Zweers,1 Kathryn Brown,1 Jan Losos,2 Peter Leone,2 Margaret Gartland,2 Paul Wannamaker,2 Max Lataillade,3 Yash Gandhi4
1Certara, Integrated Drug Development, Princeton, NJ, USA; 2ViiV Healthcare, Durham, NC, USA; 3ViiV Healthcare, Branfo








|
|
|
 |
 |
|
|